Children's Multivitamins segmentation by application reflects distinct health objectives that drive purchasing decisions and shape the market’s revenue distribution. The General Health segment, encompassing broad-spectrum formulas intended to meet daily micronutrient gaps, accounts for the largest share, roughly 45 % of total sales, because it aligns with routine pediatric recommendations and is positioned as a preventive supplement. The Immune Support segment, formulated with higher concentrations of vitamins C, D and zinc, represents about 30 % of the market; its growth is linked to heightened parental concern over seasonal infections and post‑pandemic health awareness. The Cognitive Development segment, featuring nutrients such as DHA, iron and B‑complex vitamins, contributes approximately 15 % of revenue, driven by research linking micronutrients to early learning outcomes. Finally, the Bone & Dental Health segment, focused on calcium, vitamin D and phosphorus, holds the remaining 10 % of sales, reflecting its niche positioning for children with specific skeletal or orthodontic needs. These application categories collectively define the Children’s Multivitamins market size.